Urokinase receptor: An activation antigen in human T lymphocytes

Journal of Immunology

Volumn 152, Issue 2, 1994, Pages 505-516

  Nykjær, Anders ^a   Møller, Bjarne ^b   Todd III, Robert F ^c   Christensen, Tove ^a   Andreasen, Peter A ^a   Gliemann, Jørgen ^a   Petersen, Claus Munck ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 7; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMINOGEN ACTIVATOR; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE;

ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; EXTRAVASATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE MIGRATION; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD27; BASE SEQUENCE; DNA PRIMERS; GENE EXPRESSION; HUMANS; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PHORBOL ESTERS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CELL SURFACE; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0028208975     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Vassalli, J. D., A. P. Sappino, and D. Belin. 1991. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1067.
2. Stoppelli, M. P., A. Corti, A. Soffientini, G. Cassani, F. Blasi, and R. K. Assosian. 1985. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Natl. Acad. Sci. USA 82:4939.
3. r 55,000 form of the human plasminogen activator, urokinase. J. Cell biol. 100:86.
4. r receptor protein for uroki-nase-type plasminogen activator. J. Biol. Chem. 263:2358.
5. Nykjær, A., C. M. Petersen, E. I. Christensen, O. Davidsen, and J. Gliemann. 1990. Urokinase receptors in human monocytes. Biochim. Biophys. Acta 1052:399.
6. Jensen, P. H., E. I. Christensen, P. Ebbesen, J. Gliemann, and P. A. Andreasen. 1990. Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells. Cell Regul. 1:1043.
7. Nykjær, A., C. M. Petersen, B. Møller, P. A. Andreasen, and J. Gliemann. 1992. Identification and characterization of urokinase receptors in natural killer cells and T-cell-derived lymphokine activated killer cells. FEBS Lett. 300:13.
8. Apella, E., E. A. Robinson, S. J. Ulrich, M. P. Stopelli, A. Corti, G. Cassani, and F. Blasi. 1987. The receptorbinding sequence of urokinase-biological function for the growth factor module of proteases. J. Biol. Chem. 262:4437.
9. Ploug, M., E. Rønne, N. Behrendt, A. L. Jensen, F. Blasi, and K. Danø. 1991. Cellular receptor for urokinase plasminogen activator. J. Biol. Chem. 266:1926.
10. Roldan, A. L., M. V. Cubellis, M. T. Masucci, N. Behrendt, L. R. Lund, K. Danø, E. Appella, and F. Blasi. 1990. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J. 9:467.
11. Behrendt, N., E. Rønne, M. Ploug, T. Petri, D. Løber, L. S. Nielsen, W.-D. Schleuning, F. Blasi, E. Apella, and K. Danø. 1990. The human receptor for urokinase plasminogen activator. J. Biol. Chem. 265:6453.
12. Mizukami, I. F., S. D. Vinjamuri, R. D. Trochelman, and R. F. Todd III. 1990. A structural characterization of the Mo3 activation antigen expressed on the plasma membrane of human mononuclear phagocytes. J. Immunol. 144:1841.
13. Ellis, V., N. Behrendt, and K. Danø. 1991. Plasminogen activation by receptor-bound urokinase. J. Biol. Chem. 266:12752.
14. Saksela, O., T. Hovi, and A. Vaheri. 1985. Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages. J. Cell. Physiol. 122:125.
15. Min, H. Y., R. Semnani, I. F. Mizukami, K. Watt, R. F. Todd III, and D. Y. Liu. 1992. The cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J. Immunol. 148:3636.
16. Todd, R. F. III, P. A. Alvarez, D. A. Brott, and D. Y. Liu. 1985. Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e. J. Immunol. 135:3869.
17. Todd, R. F. III, I. F. Mizukami, S. D. Vinjamuri, R. D. Trochelman, W. W. Hancock, and D. Y. Liu. 1990. Human mononuclear phagocyte activation antigens. Blood-Cells 16:167.
18. Mizukami, I. F., S. D. Vinjamuri, F. Perini, D. Y. Liu, and R. F. Todd III. 1991. Purification, biochemical composition, and biosynthesis of the Mo3 activation antigen expressed on the plasma membrane of human mononuclear phagocytes. J. Immunol. 147:1331.
19. Miles, L. A., and E. F. Plow. 1987. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase to peripheral blood cells. Thromb. Haemostas. 58:936.
20. Grøndahl-Hansen, J., E. Ralfkiær, L. S. Nielsen, P. Kristensen, G. Frentz, and K. Danø. 1987. Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. J. Invest. Dermatol. 88:28.
21. Petersen, C. M., B. K. Møller, and L. U. Lamm. 1987. HLA-DPw antigens in Danes and Eskimos as determined by local bulk PLT-reagents. Tissue Antigens 30:217.
22. 2-macroglobulin. J. Immunol. 142:629.
23. Chomezynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
24. Foumey, R. M., J. Miyakoshi, R. S. Day, and M. C. Paterson. 1988. Northern blotting: efficient RNA staining and transfer. Focus (GIBCO-BRL) 10:5.
25. Gregersen, N., J. Koch, S. Kølvraa, K. B. Petersen, and L. Bolund. 1987. Improved methods for the detection of unique sequences in Southern blots of mammalian DNA by non-radioactive biotinylated DNA hybridization probes. Clin. Chim. Acta 1969:267.
26. Feinberg, A. P., and B. Vogelstein. 1984. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:266.
27. Picone, R., E. L. Kajtaniak, L. S. Nielsen, N, Behrendt, M. R. Mastronicola, M. W. Cubellis, M. P. Stoppelli, S. Pedersen, K. Danø, and F. Blasi. 1989. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate. J. Cell. Biol. 108:693.
28. 1 in human A549 lung carcinoma cells. EMBO J. 10:3399.
29. Hashimoto, K., C. E. Whitehurst, T. Matsubara, K. Hirohata, and P. E. Lipsky. 1992. Immunomodulatory effects of therapeutic gold compounds: gold sodium thiomalate inhibits the activity of T cell protein kinase C. J. Clin. Invest. 89:1839.
30. Petersen, C. M., E. I. Christensen, B. S. Andresen, and B. K. Møller. 1992. Internalization, lysosomal degradation and new synthesis of surface membrane CD4 in phorbol ester-activated T-lymphocytes and U-937 cells. Exp. Cell Res. 201:160.
31. Armitage, R. J., A. E. Namen, H. M. Sassenfeld, and K. H. Grabstein. 1990. Regulation of human T cell proliferation by IL-7. J. Immunol. 144:938.
32. Alderson, M. R., H. M. Sassenfeld, and M. B. Widmer. 1990. Interleukin 7 enhances cytolytic lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood. J. Exp. Med. 172:577.
33. Okazaki, H., M. Ito, T. Sudo, M. Hattori, S. Kano, Y. Katsura, and N. Minato. 1989. IL-7 promotes thymocyte proliferation and maintains immunocompetent thymocytes bearing αβ or γδ receptors in vitro: synergism with IL-2. J. Immunol. 143:2917.
34. - T cells. Immunol. Lett. 20:29.
35. +) human lymphocytes. Int. J. Cancer 42:902.
36. Martinez, O. M., R. S. Gibbons, M. R. Garovoy, and F. R. Aronson. 1990. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. J. Immunol. 144:2211.
37. 1; effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma, and measurement of their endogenous production. Clin. Exp. Immunol. 82:583.
38. Smyth, M. J., S. L. Strobl, H. A. Young, J. R. Ortaldo, and A. C. Ochoa. 1991. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CDS+ T lymphocytes: inhibition with transforming growth factor-β. J. Immunol. 146:3289.
39. 1) and recombinant human tumor necrosis factor-α reciprocally regulate the generation of lymphokine-activated killer cell activity. J. Immunol. 140:2312.
40. Kirchheimer, J. C., Y.-H. Nong, and H. G. Remold. 1988. IFN-γ, tumor necrosis factor-α, and urokinase regulate the expression of urokinase receptors on human monocytes. J. Immunol. 141:4229.
41. Mignatti, P., E. Robbins, and D. B. Rifkin. 1986. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47:487.
42. Ossowski, L., and E. Reich. 1983. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35:611.
43. Ossowski, L. 1988. In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface bound urokinase. J. Cell Biol. 107:2437.
44. Meissauer, A., M. D. Kramer, M. Hofmann, L. J. Erkell, E. Jacob, V. Schirrmacher, and G. Brunner. 1992. Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells. Exp. Cell Res. 192:453.
45. Estreicher, A., J. Mühlhauser, J.-L. Carpentier, L. Orci, and J.-D. Vassalli. 1990. The receptor urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J. Cell Biol. 111:783.
46. Meeusen, E., C.-S. Lee, and M. Brandon. 1991. Differential migration of T and B cells during an acute inflammatory response. Eur. J. Immunol. 21:2269.
47. Van Hinsbergh, V. W. M., E. A. van den Berg, W. Fiers, and G. Dooijewaard. 1990. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood 75:1991.
48. Carpén, O., O. Saksela, and E. Saksela. 1986. Identification and localization of urokinase-type plasminogen activator in human NK-cells. Int. J. Cancer 38:355.
49. Brunner, G., M. M. Simon, and M. Kramer. 1990. Activation of pro-urokinase by the human T cell-associated serine proteinase HuTSP-1. FEBS Lett. 260:141.
50. Nykær, A., B. Møller, P. Andreasen, M. Kramer, T. Christensen, J. Gliemann, and C. M. Petersen. 1992. The urokinase receptor: an activation antigen coexpressed with the human T cell specific serine proteinase (HUTSP-1) in activated T lymphocytes. Fibrinolysis 6 (Suppl. 2:95; Abstr. 249).